Two persons were arrested for supplying spurious injections of Buprenorphine Hydrochloride, a controlled synthetic drug, commonly known as Norphene, police said on Saturday.
Sunil Sharma, 37, was arrested from Mayur Vihar in east Delhi while Naresh Kumar Chhikara, 53, was held in Haryana in August.
Sharma owns a godown near Mayur Vihar Phase-I, where a total of 1,40,000 ampoules of spurious injections of Norphene were recovered.
"Sharma used to get these injections manufactured at a unit being run by Chhikara in Haryana. Chhikara was arrested later, Joint Commissioner of Police (Crime Branch) Ravindra Yadav said.
Sharma, the mastermind, hails from Rohtak in Haryana and shifted to Delhi in search of employment.
Sharma used to get these spurious injections manufactured illegally at low cost and sell them, keeping a high profit margin, said the official.
Chhikara, a resident of Rohtak, runs a manufacturing unit -- "Chhikara Pharma" -- of drugs and injections in Haryana.
Police said that Norphene is used in cancer treatment and at de-addiction centres but is widely misused by drug addicts.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
